{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"11","upperLimit":"32","value":"15"}]}],"title":"Neutrophil"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"43","value":"15"}]}],"title":"Platelet"}],"denoms":[{"counts":[{"groupId":"OG000","value":"81"}],"units":"Participants"}],"description":"Median days to neutrophil and platelet recovery. Neutrophil recovery is defined as absolute neutrophil count \\>= 500 cells per microliter; platelet recovery is defined as untransfused platelet count \\>= 20 \\* 10\\^9 cells per liter.","dispersionType":"Full Range","groups":[{"description":"Rituximab (R) and high-dose cyclophosphamide (HiCy) with pegfilgrastim support.\n\nPegfilgrastim: 6 mg SQ 24-48 hours after last dose of cyclophosphamide.\n\nRituximab: 375 mg/m\\^2/day on Days 1, 4, 8, 11, 45, and 52.\n\nCyclophosphamide: 50 mg/kg/day on Days 15, 16, 17, and 18.","id":"OG000","title":"R-HiCy"}],"paramType":"MEDIAN","reportingStatus":"POSTED","timeFrame":"Up to 43 days","title":"Engraftment","type":"PRIMARY","unitOfMeasure":"days"}